Calmare Therapy (Scrambler Therapy) to Treat Diagnosed Cases of Diabetic Nerve Pain and Reduce Chronic Neuropathic Pain Symptoms

clinical trial

Phase  

Pilot

What is Diabetic Neuropathy?

Diabetic neuropathy is a type of nerve damage that can occur as a side effect from diagnosed diabetes. High blood sugar (glucose) can damage nerve fibers throughout your body, but diabetic neuropathy–nerve pain as a result of the disease of diabetes–most often damages nerves in the lower extremities (legs and feet) and the hands.

Depending on the affected nerves, symptoms of diabetic neuropathy can range from pain and numbness in the extremities to digestive, urinary tract, blood vessels and heart complications. For some people, these symptoms are mild; for others, diabetic neuropathy can be extremely painful, debilitating and disabling.

Even with stringent blood sugar control and a healthy lifestyle, some diabetic patients still experienced severe diabetic nerve pain.

Study Conducted by

Michael J. Cooney, D.C., Clinical Director

Rutherford Allied Medical Group / Calmare Therapy NJ

Location

323 Union Ave., Rutherford, New Jersey (10 miles from New York City)

Study Start Date

Monday, December 5 to Friday, December 16, 2016

Calmare Therapy NJ Background

Calmare Therapy NJ / Rutherford Allied Medical Group, is one of only ten certified providers of Calmare Pain Therapy Treatment®, an FDA-cleared, non-invasive, pain-free, drug-free technology to treat patients suffering from several types of long-term, high-intensity pain.

Since introducing the treatment in 2011, Dr. Cooney has successfully treated more than 500 patients with severe neuropathic pain as a result of injury, surgery or disease.

Scope of the Diabetic Nerve Pain Study

We are conducting a no-cost, 10-treatment (one 35-minute daily therapy session) Calmare Therapy clinical trial study for pre-qualified patients suffering from diagnosed diabetic neuropathy to determine the efficacy of scrambler therapy as a viable treatment solution for condition-induced neuropathy.

Eligibility Criteria

Selected clinical trial volunteers must be available to undergo a protocol of 10 treatments, once per day, Monday through Friday. We will make every effort to schedule daily appointments at a convenient time for participants.

Travel, daily transportation, meals and accommodations are at the trial participant’s expense

Informed Consent

Clinical trial volunteers who are selected for the study are asked to sign the Informed Consent Form. Signing this document does not require participants to remain for the duration of the study, however.

People can leave the study at any time—either before the study starts or at any time during the study or the follow-up period. The informed consent process continues throughout the study. If new benefits, risks, or side effects are discovered during the study, the researchers must inform the participants.

Publicity

Calmare Therapy NJ reserves the right to publish data about any participant’s trial outcome. We will not include your name or image, at your request.

To Apply / Contact Us / For More Information

To apply for the trial, learn more or ask questions, please contact:

Dr. Michael Cooney

Clinical Director

Calmare Therapy NJ / Rutherford Allied Medical Group

(201) 933.4440   |   calmarenj@gmail.com

Advertisements